Agilent/Dako

Monoclonal Mouse Anti-Human EGFR (Concentrate) Clone E30

#M7239 · western blot

21
Citing papers
757
Combined citations
Supplier page Find this product

Research areas

HER2/EGFR in Cancer Research6Cancer Cells and Metastasis6Breast Cancer Treatment Studies3Cancer, Hypoxia, and Metabolism3Lung Cancer Treatments and Mutations3Immune cells in cancer3Breast Lesions and Carcinomas2Fibroblast Growth Factor Research2

Papers citing this product

1
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Breast Cancer Research·2011·145 cit.·DOI
2
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
PLoS Biology·2018·97 cit.·DOI
3
iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
Molecular & Cellular Proteomics·2009·86 cit.·DOI
4
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
PLoS ONE·2019·72 cit.·DOI
5
Cancer-Associated Fibroblasts and Desmoplastic Reactions Related to Cancer Invasiveness in Patients With Colorectal Cancer
Annals of Coloproctology·2019·61 cit.·DOI
6
Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
BMC Cancer·2010·57 cit.·DOI
7
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti‐insulin‐like growth factor 1 receptor antibodies
International Journal of Cancer·2013·55 cit.·DOI
8
Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma
Oncology Letters·2016·43 cit.·DOI
9
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
Oncogene·2020·43 cit.·DOI
10
Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas
OncoTargets and Therapy·2014·32 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.